According to Fortune Business Insights, the global AI in pathology market size was valued at USD 141.6 million in 2025 and is projected to grow from USD 174.0 million in 2026 to USD 1,075.2 million by 2034, exhibiting a CAGR of 25.56% during the forecast period. North America dominated the global market with a share of 48.59% in 2025.
The market is expected to expand steadily over the forecast period, supported by rising demand for precision medicine and advancements in digital pathology infrastructure. AI in pathology is particularly gaining traction in oncology, where accurate and early diagnosis is critical for effective treatment planning.
The global AI in pathology market is witnessing significant growth, driven by the increasing adoption of artificial intelligence technologies in diagnostic workflows. AI-powered tools are transforming pathology by enhancing accuracy, reducing turnaround times, and enabling early disease detection. The integration of machine learning, deep learning, and computer vision into pathology processes is reshaping how medical professionals analyze tissue samples and diagnose diseases.
Information Source: https://www.fortunebusinessinsights.com/ai-in-pathology-market-111753
Market Size and Growth Outlook
The AI in pathology market is still in its early stages but is growing rapidly due to increasing investments in healthcare AI technologies. Estimates from industry analyses suggest that the market was valued at over USD 100 million in the mid-2020s and is projected to surpass USD 1 billion by 2034, exhibiting a strong double-digit CAGR.
This growth is closely linked to the broader expansion of artificial intelligence in healthcare and diagnostics. The increasing digitization of pathology laboratories and the adoption of whole-slide imaging systems are enabling seamless integration of AI tools into clinical workflows. Additionally, the growing burden of chronic diseases such as cancer is driving the need for faster and more accurate diagnostic solutions.
Key Market Drivers
One of the primary drivers of the AI in pathology market is the rising prevalence of cancer worldwide. Pathology plays a crucial role in cancer diagnosis, and AI technologies are helping pathologists identify patterns and anomalies with greater precision. AI algorithms can analyze large datasets of histopathological images, improving diagnostic accuracy and reducing human error.
Another major factor is the shortage of skilled pathologists globally. AI solutions help bridge this gap by automating routine tasks such as cell counting, image analysis, and pattern recognition. This allows pathologists to focus on complex cases, improving overall efficiency in laboratories.
Furthermore, advancements in digital pathology are accelerating market growth. The transition from traditional microscopy to digital imaging systems enables the storage, sharing, and analysis of pathology data, which is essential for AI implementation. The increasing use of cloud-based platforms also facilitates remote diagnostics and collaboration among healthcare professionals.
Market Segmentation
The AI in pathology market can be segmented based on component, application, and end-user.
By component, the market includes software, hardware, and services. Among these, software solutions dominate the market due to their ability to analyze and interpret medical images using AI algorithms.
In terms of application, the market covers disease diagnosis, drug discovery, and training & education. Disease diagnosis holds the largest share, as AI is widely used for detecting cancer and other chronic conditions.
By end-user, the market is segmented into hospitals, diagnostic laboratories, and research institutions. Hospitals and laboratories account for the largest share due to the high volume of diagnostic procedures conducted in these settings.
Regional Insights
North America dominates the AI in pathology market, driven by advanced healthcare infrastructure, high adoption of digital technologies, and strong presence of key market players. The region also benefits from significant investments in AI research and development.
Europe is another prominent market, with increasing adoption of digital pathology solutions and supportive government initiatives. Meanwhile, the Asia Pacific region is expected to witness the fastest growth during the forecast period. This growth is attributed to rising healthcare expenditure, growing awareness of AI technologies, and increasing demand for efficient diagnostic solutions in countries such as China and India.
Competitive Landscape and Key Players
The AI in pathology market is highly competitive, with several global and regional players focusing on innovation and strategic partnerships. Companies are investing in research and development to enhance their AI capabilities and expand their product portfolios.
Key players in the market include:
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- GE HealthCare
- Leica Biosystems (Danaher Corporation)
- PathAI, Inc.
- Paige AI, Inc.
- Inspirata, Inc.
- Aiforia Technologies Plc
- Visiopharm A/S
These companies are actively developing AI-based pathology solutions and collaborating with healthcare providers to improve diagnostic outcomes.
Future Outlook
The future of the AI in pathology market looks promising, with continuous advancements in artificial intelligence and digital healthcare technologies. The integration of AI with other emerging technologies such as big data analytics and cloud computing is expected to further enhance diagnostic capabilities.
Moreover, increasing regulatory approvals for AI-based diagnostic tools will boost market adoption. As healthcare systems worldwide focus on improving efficiency and patient outcomes, AI in pathology is set to play a crucial role in the evolution of diagnostic practices.
Top comments (0)